Phase II Study of Pembrolizumab in Conjunction with Lymphodepletion, TIL ACT, and High- or Low-Dose IL-2 in Patients with Metastatic Melanoma
Merve Hasanov,Simin Kiany,Marie-Andree Forget,Roland L. Bassett,Michael A. Davies,Adi Diab,Jeffrey E. Gershenwald,Isabella C. Glitza,Jeffrey E. Lee,Anthony Lucci,Jennifer L. McQuade,Sapna P. Patel,Merrick I. Ross,Hussein A. Tawbi,Jennifer Wargo,Michael K. Wong,Chantale Bernatchez,Patrick Hwu,Cara Haymaker,Rodabe N. Amaria Cancer Research（2024）
AI 理解论文
溯源树
样例
